Alert Issued on Surgical Mesh for Pelvic Organ Prolapse and SUI

Share this content:

The FDA has issued an alert to health-care professionals and the public after receiving reports of complications from the use of surgical mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

 

The placement of mesh through an incision made in the wall of the vagina has resulted, in rare cases, in erosion through the vagina, infection, pain, urinary problems, and recurrence of POP and/or SUI.

 

These reports have not been linked to a single brand or model of mesh. Before having an operation for POP or SUI, patients are advised to let their surgeon know if they've had a past reaction to mesh materials such as polypropylene and to ask questions about options and consequences.

 

POP occurs when a pelvic organ, such as the bladder, the uterus, the bowel or rectum, drops from its normal position and pushes against the vaginal wall. SUI is leakage of urine during moments of physical stress.

You must be a registered member of Renal and Urology News to post a comment.